University sues Gilead for patent infringement
The University of Minnesota has filed a lawsuit against Gilead Sciences claiming that the drugmaker’s hepatitis C drugs violate its intellectual property.
Read More
Tag: University of Minnesota
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
